NZ184806A - 1,5-disubstituted 2-pyrrolidine derivatives pharmaceutical compositions intermediates - Google Patents

1,5-disubstituted 2-pyrrolidine derivatives pharmaceutical compositions intermediates

Info

Publication number
NZ184806A
NZ184806A NZ184806A NZ18480677A NZ184806A NZ 184806 A NZ184806 A NZ 184806A NZ 184806 A NZ184806 A NZ 184806A NZ 18480677 A NZ18480677 A NZ 18480677A NZ 184806 A NZ184806 A NZ 184806A
Authority
NZ
New Zealand
Prior art keywords
disubstituted
intermediates
pharmaceutical compositions
pyrrolidine derivatives
derivatives pharmaceutical
Prior art date
Application number
NZ184806A
Inventor
A J Nelson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NZ184806A publication Critical patent/NZ184806A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ184806A 1976-08-06 1977-08-02 1,5-disubstituted 2-pyrrolidine derivatives pharmaceutical compositions intermediates NZ184806A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (1)

Publication Number Publication Date
NZ184806A true NZ184806A (en) 1980-04-28

Family

ID=24861795

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ184806A NZ184806A (en) 1976-08-06 1977-08-02 1,5-disubstituted 2-pyrrolidine derivatives pharmaceutical compositions intermediates

Country Status (31)

Country Link
JP (2) JPS5321159A (en)
AR (1) AR217080A1 (en)
AT (1) AT362887B (en)
AU (1) AU508007B2 (en)
BE (1) BE857506A (en)
BG (1) BG31073A3 (en)
CA (1) CA1077948A (en)
CH (1) CH624934A5 (en)
CS (1) CS221269B2 (en)
DD (2) DD136135A5 (en)
DE (1) DE2735904A1 (en)
DK (1) DK352077A (en)
ES (2) ES461388A1 (en)
FI (1) FI70009C (en)
FR (1) FR2369260A1 (en)
GB (2) GB1556570A (en)
GR (1) GR68688B (en)
HU (1) HU180273B (en)
IE (1) IE45505B1 (en)
IL (1) IL52615A (en)
LU (1) LU77936A1 (en)
NL (1) NL7708637A (en)
NO (1) NO772752L (en)
NZ (1) NZ184806A (en)
PH (1) PH17398A (en)
PL (2) PL112931B1 (en)
PT (1) PT66891B (en)
SE (1) SE423813B (en)
SU (3) SU703016A3 (en)
YU (1) YU192577A (en)
ZA (1) ZA774704B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
JPS59137224A (en) * 1983-01-25 1984-08-07 Mitsubishi Electric Corp Feed voltage compensator for electric railroad
IL141120A0 (en) 2000-01-31 2002-02-10 Pfizer Prod Inc Use of prostaglandin (pge2) receptor 4 (epa) selective agonists for the treatment of acute and chronic renal failure
WO2002024647A1 (en) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
MXPA03004623A (en) * 2000-11-27 2003-09-05 Pfizer Prod Inc Ep4 receptor selective agonists in the treatment of osteoporosis.
WO2003009872A1 (en) * 2001-07-23 2003-02-06 Ono Pharmaceutical Co., Ltd. Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
ES2268327T3 (en) * 2002-03-18 2007-03-16 Pfizer Products Inc. USE OF A SELECTIVE OF AN EP4 RECEIVER FOR THE TREATMENT OF DISEASES.
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
JP4582456B2 (en) * 2003-01-21 2010-11-17 小野薬品工業株式会社 8-Azaprostaglandin derivatives and pharmaceutical use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (en) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22PIRORIDONJUDOTAINO SEIHO
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (en) * 1975-06-27 1977-01-13 Hoechst Ag PYRROLIDONE AND THE METHOD FOR MANUFACTURING THEIR

Also Published As

Publication number Publication date
DD143768A5 (en) 1980-09-10
SE7708642L (en) 1978-02-07
LU77936A1 (en) 1978-04-27
GR68688B (en) 1982-02-01
FI70009C (en) 1986-09-12
PH17398A (en) 1984-08-08
PT66891B (en) 1979-01-26
DD136135A5 (en) 1979-06-20
IE45505L (en) 1978-02-06
JPS5321159A (en) 1978-02-27
CA1077948A (en) 1980-05-20
FR2369260B1 (en) 1982-02-12
YU192577A (en) 1983-04-30
ES471349A1 (en) 1979-09-16
JPS5555161A (en) 1980-04-22
BE857506A (en) 1978-02-06
PL200124A1 (en) 1978-05-22
HU180273B (en) 1983-02-28
JPS585196B2 (en) 1983-01-29
AR217080A1 (en) 1980-02-29
IL52615A (en) 1981-09-13
CH624934A5 (en) 1981-08-31
PT66891A (en) 1977-09-01
AU2751577A (en) 1979-02-08
SE423813B (en) 1982-06-07
SU818480A3 (en) 1981-03-30
GB1556570A (en) 1979-11-28
IL52615A0 (en) 1977-10-31
NO772752L (en) 1978-02-07
FI772376A (en) 1978-02-07
DK352077A (en) 1978-02-07
DE2735904A1 (en) 1978-02-09
FI70009B (en) 1986-01-31
ZA774704B (en) 1978-06-28
ATA579477A (en) 1980-11-15
BG31073A3 (en) 1981-10-15
NL7708637A (en) 1978-02-08
IE45505B1 (en) 1982-09-08
AU508007B2 (en) 1980-03-06
PL112931B1 (en) 1980-11-29
CS221269B2 (en) 1983-04-29
SU850000A3 (en) 1981-07-23
FR2369260A1 (en) 1978-05-26
JPS5531147B2 (en) 1980-08-15
ES461388A1 (en) 1978-12-01
AT362887B (en) 1981-06-25
GB1556569A (en) 1979-11-28
SU703016A3 (en) 1979-12-05

Similar Documents

Publication Publication Date Title
ZA78143B (en) Therapeutically useful 3,4,5-trimethoxybenzene derivatives
GB2035303B (en) 2,3-dicyano-hydroquinone derivatives
AU3921478A (en) 3,4,5 trihydroxypiperidine derivatives
AU2014476A (en) 1,2,4-triazole derivatives
GB2041361B (en) 1,2-dihydro-2-oxo-4-phenyl-3-quinolinecarbonitrile derivatives
NZ184806A (en) 1,5-disubstituted 2-pyrrolidine derivatives pharmaceutical compositions intermediates
NZ188946A (en) 1,2-benzisoxazoloxyacetic acid derivatives pharmaceutical compositions
IL49931A (en) Pharmaceutical compositions comprising 1-phenyl-2,3,4,5-tetrahydro-1h-benzazepine derivatives and certain new such compounds
NZ195144A (en) 3-(imidazol-2-yl)-3-phenyl-alkylamines pharmaceutical compositions
ZA807494B (en) 2,3-indoledione derivatives
GB2017093B (en) 3,3-dichloro-2-azetidinone derivatives
ZA791241B (en) 1.1 diphenylethene derivatives as microbicides
PH19393A (en) 1,3-dithiolan-2-yl(1,3-dithian-2-yl)derivatives
GR61590B (en) 2,1,3-benzothiazins substituted compositions
IL54517A0 (en) New 3,5-disubstituted-1h-1,2,4-triazole derivatives
PT68947A (en) 2,3-dicyanopyrazine derivatives
NZ182062A (en) 4-pyrazol-3-4l-4h-1,2,4-triazole derivatives and herbicidal compositions
PH13909A (en) 17(-acetylenic-androstenes,the pharmaceutical composition
GB2017104B (en) 4-thia-2,6-diaza-bicyclo-(3,2,0-)-heptane derivatives
IL56239A0 (en) Pharmaceutical compositions comprising certain 1,3-bis-chromonyloxy-2-hydroxypropane derivatives
AU505115B2 (en) N, n'diphenyl-guanidine derivatives
IL55208A0 (en) Novel pharmaceutical compositions comprising certain imidazole derivatives
IL59681A0 (en) 2,o-dihydro-1,j-bezodioxane derivatives
IL54002A0 (en) Pharmaceutical compositions comprising certain 1,2,4-triazole derivatives
GB2013678B (en) 1,4 benzoazine derivatives